Fingerprint
Dive into the research topics of 'Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically